The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
We are building Definium to be a leader in psychiatry, focused on delivering a differentiated, scalable franchise for patients with depression, anxiety, and trauma, anchored by DT120 ODT, which we ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects for the development of drugs for ...
Statin come with heavy baggage. I decided to treat a knowledge gap using my own body in a blinded crossover ...
The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
LB Pharmaceuticals Inc (LBRX) 25th Annual Needham Virtual Healthcare Conference April 16, 2026 11:45 AM EDTCompany ParticipantsHeather Turner - CEO ...
Morning Overview on MSN
New bowel cancer approach keeps disease at bay for 3 years
Every patient enrolled in a groundbreaking rectal cancer trial has remained disease-free for more than three years after ...
Researchers and clinicians investigating topical insulin in eye care discuss their research and its potential future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results